HC Wainwright Issues Pessimistic Forecast for AXSM Earnings
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – HC Wainwright dropped their Q2 2025 earnings per share estimates for shares of Axsome Therapeutics in a research report issued to clients and investors on Wednesday, May 7th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of ($0.85) per share for the […]
